Havens Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Havens Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,000	Closed	-$1.9M	–	39
2019 Q3	$1.9M	Buy	+28,000	New	+$1.92M	1.73%	16

Havens Advisors's GHDX Position: Q4 2019 in Review

Havens Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 28,000 shares — an estimated $1.9M sold.

Havens Advisors first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $1.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Havens Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Havens Advisors sold 28,000 Genomic Health, Inc. shares in Q4 2019, an estimated $1.9M.
Havens Advisors first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
Havens Advisors's Genomic Health, Inc. position peaked at $1.9M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.